Yulan Cheng

7.4k total citations
118 papers, 5.1k citations indexed

About

Yulan Cheng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yulan Cheng has authored 118 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 43 papers in Cancer Research and 33 papers in Surgery. Recurrent topics in Yulan Cheng's work include Cancer-related molecular mechanisms research (25 papers), Esophageal Cancer Research and Treatment (20 papers) and RNA modifications and cancer (18 papers). Yulan Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (25 papers), Esophageal Cancer Research and Treatment (20 papers) and RNA modifications and cancer (18 papers). Yulan Cheng collaborates with scholars based in United States, China and Japan. Yulan Cheng's co-authors include Stephen J. Meltzer, Keith T. Wilson, John Abraham, Yuriko Mori, Xuemei Chen, Zhe Jin, Alain P. Gobert, Rachana Agarwal, Robert A. Casero and Jamie C. Newton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Biological Chemistry.

In The Last Decade

Yulan Cheng

110 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulan Cheng United States 42 3.3k 1.7k 1.3k 701 506 118 5.1k
Mei Huang China 41 3.5k 1.1× 1.3k 0.8× 619 0.5× 808 1.2× 652 1.3× 123 6.1k
Limin Liu China 39 3.1k 0.9× 828 0.5× 334 0.3× 556 0.8× 650 1.3× 167 5.2k
Lijuan Wang China 36 2.6k 0.8× 1.9k 1.1× 383 0.3× 372 0.5× 968 1.9× 146 4.4k
Jian‐Ying Wang United States 49 5.0k 1.5× 2.3k 1.4× 648 0.5× 465 0.7× 476 0.9× 150 6.4k
Xianghong Zhang China 32 1.6k 0.5× 875 0.5× 359 0.3× 500 0.7× 378 0.7× 150 3.2k
Shu-Hwa Chen Taiwan 16 2.8k 0.9× 1.0k 0.6× 215 0.2× 646 0.9× 496 1.0× 22 5.0k
Yue Zhang China 39 3.1k 1.0× 1.7k 1.0× 360 0.3× 359 0.5× 628 1.2× 200 5.0k
Zhe Zhang China 35 3.0k 0.9× 1.6k 0.9× 187 0.1× 494 0.7× 451 0.9× 162 4.6k
Vito Michele Fazio Italy 39 3.3k 1.0× 992 0.6× 423 0.3× 774 1.1× 779 1.5× 167 5.3k
Maeve O’Sullivan United States 31 2.0k 0.6× 871 0.5× 356 0.3× 447 0.6× 397 0.8× 108 4.3k

Countries citing papers authored by Yulan Cheng

Since Specialization
Citations

This map shows the geographic impact of Yulan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulan Cheng more than expected).

Fields of papers citing papers by Yulan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulan Cheng. The network helps show where Yulan Cheng may publish in the future.

Co-authorship network of co-authors of Yulan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yulan Cheng. A scholar is included among the top collaborators of Yulan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulan Cheng. Yulan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manyam, Ganiraju C., Vibhuti Srivastava, Jueping Song, et al.. (2025). Chromosome 20q gene signature associated with colorectal cancer progression. Oncology Reports. 54(4). 1–11.
2.
Kann, Lisa, Suji Kim, Andrew Kalra, et al.. (2025). Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus. The American Journal of Gastroenterology. 120(6). 1285–1295. 5 indexed citations
3.
Cheng, Yulan, Xiangdong Wang, Rong Huang, et al.. (2025). Associations between brominated flame retardants exposure and non-alcoholic fatty liver disease: Mediation analysis in the NHANES. Ecotoxicology and Environmental Safety. 290. 117762–117762. 4 indexed citations
4.
Kong, Shuai, Dan Zhou, Yulan Cheng, et al.. (2024). Establishing mouse and human oral esophageal organoids to investigate the tumor immune response. Disease Models & Mechanisms. 17(1). 7 indexed citations
5.
6.
Cheng, Yulan, Andrew Kalra, Ke Ma, et al.. (2022). Generation and multiomic profiling of aTP53/CDKN2Adouble-knockout gastroesophageal junction organoid model. Science Translational Medicine. 14(673). eabq6146–eabq6146. 25 indexed citations
7.
Peng, Yin, Ying� Qin, Xiaojing Zhang, et al.. (2021). MiRNA-20b/SUFU/Wnt axis accelerates gastric cancer cell proliferation, migration and EMT. Heliyon. 7(4). e06695–e06695. 17 indexed citations
8.
Wang, Zhixiong, Swetha Kambhampati, Yulan Cheng, et al.. (2019). Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study. Clinical Cancer Research. 25(7). 2127–2135. 42 indexed citations
9.
10.
Wang, Zhe, Ke Ma, Yulan Cheng, et al.. (2018). Novel circular RNA circNF1 acts as a molecular sponge, promoting gastric cancer by absorbing miR-16. Endocrine Related Cancer. 26(3). 265–277. 53 indexed citations
11.
Wang, Zhixiong, Yulan Cheng, John Abraham, et al.. (2017). RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1‐MELK, arising from a complex chromosomal rearrangement. Cancer. 123(20). 3916–3924. 17 indexed citations
12.
Bi, Xiuli, Xin Song, Nicole M. Pohl, et al.. (2013). A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular Carcinogenesis. 52(S1). 80–86. 14 indexed citations
13.
Yang, Xue, Jueping Song, Yulan Cheng, et al.. (2013). Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 63(6). 881–890. 182 indexed citations
14.
Kathiria, Arwa S., William L. Neumann, Jennifer Rhees, et al.. (2012). Prohibitin Attenuates Colitis-Associated Tumorigenesis in Mice by Modulating p53 and STAT3 Apoptotic Responses. Cancer Research. 72(22). 5778–5789. 49 indexed citations
15.
Mori, Yuriko, Alexandru Olaru, Yulan Cheng, et al.. (2011). Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine Related Cancer. 18(4). 465–478. 63 indexed citations
16.
Ito, Tetsuo, Yutaka Shimada, Takatsugu Kan, et al.. (2008). Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Cancer Research. 68(9). 3214–3224. 44 indexed citations
17.
Jin, Zhe, Alexandru Olaru, Jian Yang, et al.. (2007). Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer. Clinical Cancer Research. 13(21). 6293–6300. 67 indexed citations
18.
Hamilton, James P., Fumiaki Sato, Zhe Jin, et al.. (2006). Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression. Clinical Cancer Research. 12(22). 6637–6642. 39 indexed citations
19.
Gobert, Alain P., Yulan Cheng, Mahmood Akhtar, et al.. (2004). Protective Role of Arginase in a Mouse Model of Colitis. The Journal of Immunology. 173(3). 2109–2117. 110 indexed citations
20.
Gobert, Alain P., Yulan Cheng, Jian-Ying Wang, et al.. (2002). Helicobacter pylori Induces Macrophage Apoptosis by Activation of Arginase II. The Journal of Immunology. 168(9). 4692–4700. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Huang Breakdown of academic impact, for papers by Limin Liu Breakdown of academic impact, for papers by Lijuan Wang Breakdown of academic impact, for papers by Jian‐Ying Wang Breakdown of academic impact, for papers by Xianghong Zhang Breakdown of academic impact, for papers by Shu-Hwa Chen Breakdown of academic impact, for papers by Yue Zhang Breakdown of academic impact, for papers by Zhe Zhang Breakdown of academic impact, for papers by Vito Michele Fazio Breakdown of academic impact, for papers by Maeve O’Sullivan
Rankless by CCL
2026